CERK and cancer: Also, safingol (L-threo-dihydrosphingosine), a potent sphingosine kinase (SK) inhibitor, is commonly used in cancer therapy to avoid formation of S1P, and the recently identified inhibitor of ceramide kinase, F-1209A, can be used to inhibit C1P generation (Kim et al. 2005).